BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 29054751)

  • 1. NG2/CSPG4 and progranulin in the posttraumatic glial scar.
    Schäfer MKE; Tegeder I
    Matrix Biol; 2018 Aug; 68-69():571-588. PubMed ID: 29054751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NG2+ progenitors derived from embryonic stem cells penetrate glial scar and promote axonal outgrowth into white matter after spinal cord injury.
    Vadivelu S; Stewart TJ; Qu Y; Horn K; Liu S; Li Q; Silver J; McDonald JW
    Stem Cells Transl Med; 2015 Apr; 4(4):401-11. PubMed ID: 25713464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular mechanisms of scar-sourced axon growth inhibitors.
    Ohtake Y; Li S
    Brain Res; 2015 Sep; 1619():22-35. PubMed ID: 25192646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Significance of Chondroitin Sulfate Proteoglycan 4 (CSPG4) in Human Gliomas.
    Schiffer D; Mellai M; Boldorini R; Bisogno I; Grifoni S; Corona C; Bertero L; Cassoni P; Casalone C; Annovazzi L
    Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30213051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of chondroitin sulfate proteoglycan 4 (NG2/CSPG4) on soft-tissue sarcoma growth depend on tumor developmental stage.
    Hsu SC; Nadesan P; Puviindran V; Stallcup WB; Kirsch DG; Alman BA
    J Biol Chem; 2018 Feb; 293(7):2466-2475. PubMed ID: 29196603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Entrapment via synaptic-like connections between NG2 proteoglycan+ cells and dystrophic axons in the lesion plays a role in regeneration failure after spinal cord injury.
    Filous AR; Tran A; Howell CJ; Busch SA; Evans TA; Stallcup WB; Kang SH; Bergles DE; Lee SI; Levine JM; Silver J
    J Neurosci; 2014 Dec; 34(49):16369-84. PubMed ID: 25471575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chondroitin sulfate proteoglycans: Key modulators in the developing and pathologic central nervous system.
    Dyck SM; Karimi-Abdolrezaee S
    Exp Neurol; 2015 Jul; 269():169-87. PubMed ID: 25900055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myelin-, reactive glia-, and scar-derived CNS axon growth inhibitors: expression, receptor signaling, and correlation with axon regeneration.
    Sandvig A; Berry M; Barrett LB; Butt A; Logan A
    Glia; 2004 May; 46(3):225-51. PubMed ID: 15048847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell surface chondroitin sulphate proteoglycan 4 (CSPG4) binds to the basement membrane heparan sulphate proteoglycan, perlecan, and is involved in cell adhesion.
    Tang F; Lord MS; Stallcup WB; Whitelock JM
    J Biochem; 2018 May; 163(5):399-412. PubMed ID: 29462330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NG2: a component of the glial scar that inhibits axon growth.
    Tan AM; Zhang W; Levine JM
    J Anat; 2005 Dec; 207(6):717-25. PubMed ID: 16367799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The chondroitin sulfate proteoglycans neurocan and phosphacan are expressed by reactive astrocytes in the chronic CNS glial scar.
    McKeon RJ; Jurynec MJ; Buck CR
    J Neurosci; 1999 Dec; 19(24):10778-88. PubMed ID: 10594061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in distribution, cell associations, and protein expression levels of NG2, neurocan, phosphacan, brevican, versican V2, and tenascin-C during acute to chronic maturation of spinal cord scar tissue.
    Tang X; Davies JE; Davies SJ
    J Neurosci Res; 2003 Feb; 71(3):427-44. PubMed ID: 12526031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Function of NG2/CSPG4-expressing Cells in the Rat Spinal Cord Injury: An Immunoelectron Microscopy Study.
    Kabdesh IM; Arkhipova SS; Mukhamedshina YO; James V; Rizvanov AA; Chelyshev YA
    Neuroscience; 2021 Jul; 467():142-149. PubMed ID: 34102261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Scar-mediated inhibition and CSPG receptors in the CNS.
    Sharma K; Selzer ME; Li S
    Exp Neurol; 2012 Oct; 237(2):370-8. PubMed ID: 22836147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased expression of the NG2 chondroitin-sulfate proteoglycan after brain injury.
    Levine JM
    J Neurosci; 1994 Aug; 14(8):4716-30. PubMed ID: 8046446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of platelet-derived growth factor receptor β reduces reactive glia and scar formation after traumatic brain injury in mice.
    Pei D; Liu N; Li D; Yan H; Wang QB; Fang Y; Xie L; Li HP
    Brain Res Bull; 2017 Sep; 134():121-127. PubMed ID: 28684344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NG2 is a major chondroitin sulfate proteoglycan produced after spinal cord injury and is expressed by macrophages and oligodendrocyte progenitors.
    Jones LL; Yamaguchi Y; Stallcup WB; Tuszynski MH
    J Neurosci; 2002 Apr; 22(7):2792-803. PubMed ID: 11923444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor on glial scar formation after spinal cord injury in rats.
    Chung J; Kim MH; Yoon YJ; Kim KH; Park SR; Choi BH
    J Neurosurg Spine; 2014 Dec; 21(6):966-73. PubMed ID: 25279652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NG2 proteoglycan-expressing cells of the adult rat brain: possible involvement in the formation of glial scar astrocytes following stab wound.
    Alonso G
    Glia; 2005 Feb; 49(3):318-38. PubMed ID: 15494983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of NG2 exacerbates neurological outcome and modulates glial responses after traumatic brain injury.
    Huang C; Sakry D; Menzel L; Dangel L; Sebastiani A; Krämer T; Karram K; Engelhard K; Trotter J; Schäfer MK
    Glia; 2016 Apr; 64(4):507-23. PubMed ID: 26638112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.